Behandlingens effekt hos RLS- patienten og den forsatte behandling bør evalueres efter 3 måneders brug, eftersom langtidsvirkningen af Mirapexin ikke er tilstrækkelig kendt.
As long-term efficacy of MIRAPEXIN in the treatment of RLS has not been sufficiently tested, patient´s response should be evaluated after 3 months treatment and the need for treatment continuation should be reconsidered.